As the population ages, the COVID tailwind persists, and mounting pressure on healthcare services starts to take its toll, the need for new and improved MedTech solutions grows.
As detailed in the UK government’s 2021 Life Sciences Vision report, recent advances in the life sciences have improved the length and quality of life on a global scale. A great deal has changed in the two years since that report, including the needs of the people.
Advancements in MedTech have made a shift from facility to in-home healthcare, without sacrificing quality, easier than ever before. Take SugarIQ, IBM’s collaborative project with Medtronic, a diabetes management app that can make real-time predictions and provide actionable insights.
There’s also Proteus, the brand responsible for the world’s first FDA-approved ingestible digital sensor, a patient-centric device designed to make the remote monitoring of drug compliance seamless. The project ultimately fell through when Proteus filed for bankruptcy in 2020, but it stands as a lesson for today’s MedTech start-ups, one of which being the extraordinary value of sourcing and retaining top talent.
These projects (and many others like them) represent the dawn of a new era in at-home medicine, and potentially an industry-defining move away from traditional facility-based models. Like most areas at the precipice of innovation, the regulations, methodologies and infrastructures take a while to catch up with the technology — the fate of Proteus is, in many ways, a prime example.
Healthcare systems remain under constant high pressure, be it the NHS or the US healthcare infrastructure — we’ve seen an increase in waiting times, a lack of beds, understaffing, and poor access to GPs across the board. MedTech could serve as a way to ease some of those pressures, provided there’s an increase in take-up.
Virtual appointments have been around for a while now, but MedTech’s potential stretches far beyond the diagnosis stage, acting as a real-time, real-world personal assistant to patients everywhere.
Behind every great innovation is an even greater team of individuals. Advancements in the MedTech space have given rise to a greater need for increasingly versatile STEM candidates. Here at BioTalent, we’ve worked closely with many of the world’s MedTech companies, from multinationals to brand-new start-ups with big ambitions, and we’ve been able to deliver the talent that fits their unique needs.
Whether you’re looking to build a team from the ground up, or you’re in the market for a new career of your own, our diversity-led hiring methodology ensures that we always put people first when it comes to life sciences recruitment. If this sounds like something you’d be interested in, reach out to the team at BioTalent below.